Lineage tracing demonstrates no evidence of cholangiocyte epithelial‐to‐mesenchymal transition in murine models of hepatic fibrosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.24206PMID 21520179PMCID PMC3082729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of stem cells in liver repair and fibrosis.

  2011cited by this paper
• HEPATIC FIBROSIS : Pathogenesis and Principles of Therapy

  2011cited by this paper
• Portal fibroblasts: Underappreciated mediators of biliary fibrosis

  2010cited by this paper
• Fate-determining mechanisms in epithelial–myofibroblast transition: major inhibitory role for Smad3

  2010cited by this paper
• Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition

  2010cited by this paper
• Hepatocytes do not undergo epithelial‐mesenchymal transition in liver fibrosis in mice

  2010cited by this paper
• Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice.

  2010cited by this paper
• Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive?

  2010cited by this paper
• The epithelial‐to‐mesenchymal transition in liver fibrosis: Here today, gone tomorrow?

  2010cited by this paper
• Epithelial and Mesenchymal Cell Biology Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney

  2010cited by this paper
• Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development

  2009cited by this paper
• Notch signaling controls liver development by regulating biliary differentiation

  2009cited by this paper
• TGF-β-induced epithelial to mesenchymal transition

  2009cited by this paper
• Biomarkers for epithelial-mesenchymal transitions.

  2009cited by this paper
• Epithelial–mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia

  2009cited by this paper
• Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

  2009cited by this paper
• Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

  2009cited by this paper
• Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease

  2008cited by this paper
• Transdifferentiation into biliary ductular cells of hepatocytes transplanted into the spleen

  2008cited by this paper
• Fate‐Mapping Evidence That Hepatic Stellate Cells Are Epithelial Progenitors in Adult Mouse Livers

  2008cited by this paper
• Identification of an Evolutionarily Conserved Transcriptional Signature of CD8 Memory Differentiation That Is Shared by T and B Cells1

  2008cited by this paper
• Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases

  2008cited by this paper
• Origin of stellate cells from submesothelial cells in a developing human liver

  2008cited by this paper
• Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis.

  2008cited by this paper
• Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver.

  2008cited by this paper
• Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation

  2008cited by this paper
• Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.

  2008cited by this paper
• Biliary epithelial‐mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis

  2007cited by this paper
• Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway.

  2007cited by this paper
• Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver

  2007cited by this paper
• Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition*

  2007influential reference
• Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat.

  2007cited by this paper
• Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

  2006cited by this paper
• Hepatic stellate cells do not derive from the neural crest.

  2006cited by this paper
• Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages.

  2006cited by this paper
• Transplantation of fetal liver epithelial progenitor cells ameliorates experimental liver fibrosis in mice.

  2006cited by this paper
• Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion

  2005cited by this paper
• Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys

  2005cited by this paper
• Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro.

  2005cited by this paper
• Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo

  2005cited by this paper
• Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury

  2005cited by this paper
• Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin.

  2004cited by this paper
• The Origin of Biliary Ductular Cells that Appear in the Spleen after Transplantation of Hepatocytes

  2004cited by this paper
• Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers

  2004cited by this paper
• The origin and liver repopulating capacity of murine oval cells

  2003cited by this paper
• Timing and sequence of differentiation of embryonic rat hepatocytes along the biliary epithelial lineage

  2003cited by this paper
• Immunohistochemical evidence for hepatic progenitor cells in liver diseases.

  2002influential reference
• S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes

  2002cited by this paper
• Hepatic fibrosis. Pathogenesis and principles of therapy.

  2001cited by this paper
• Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

  2001cited by this paper
• Regulation of cholangiocyte proliferation.

  2001cited by this paper
• Hepatocyte‐specific expression of Cre recombinase

  2000cited by this paper
• Proliferation and differentiation of fetal liver epithelial progenitor cells after transplantation into adult rat liver.

  2000cited by this paper
• Small epithelial cells in extrahepatic biliary atresia: electron microscopic and immunoelectron microscopic findings suggest a close relationship to liver progenitor cells

  1999cited by this paper
• A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections.

  1999cited by this paper
• Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.

  1998cited by this paper
• Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation.

  1998cited by this paper
• Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation.

  1998cited by this paper
• Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction.

  1998cited by this paper
• Dual phenotypic expression of hepatocytes and bile ductular markers in developing and preneoplastic rat liver.

  1996cited by this paper
• Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced.

  1995cited by this paper
• α-Smooth-muscle actin expression in normal and fibrotic human livers

  1993cited by this paper

• MEOX1-mediated transcriptional regulation of circABHD3 exacerbates hepatic fibrosis through promoting m6A/YTHDF2-dependent YPEL3 mRNA decay to activate β-catenin signaling

  2025cites this paper
• Innate immunity of bile and cholangiocytes in primary biliary cholangitis

  2025cites this paper
• Liver fibrosis pathologies and potentials of RNA based therapeutics modalities

  2024cites this paper
• Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells

  2024cites this paper
• Epithelial–mesenchymal transition in tissue repair and degeneration

  2024cites this paper
• The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols

  2024cites this paper
• Liver fibrosis: Our evolving understanding.

  2024cites this paper
• Systematic review of the mechanism and assessment of liver fibrosis in biliary atresia

  2024cites this paper
• Lack of basic rationale in epithelial-mesenchymal transition and its related concepts

  2024cites this paper
• Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children

  2023cites this paper
• Fetal liver development and implications for liver disease pathogenesis

  2023cites this paper
• Isolation of primary human liver cells from normal and nonalcoholic steatohepatitis livers

  2023cites this paper
• Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma

  2023cites this paper
• Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted

  2023cites this paper
• Modern concepts on pathogenetic mechanisms of liver fibrosis

  2023cites this paper
• The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts

  2023cites this paper
• Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis

  2022cites this paper
• Wound healing, fibroblast heterogeneity, and fibrosis.

  2022cites this paper
• Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.

  2022cites this paper
• Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis

  2022influential citation
• Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis

  2021cites this paper
• Clonorchis sinensis Granulin Promotes Malignant Transformation of Hepatocyte Through EGFR-Mediated RAS/MAPK/ERK and PI3K/Akt Signaling Pathways

  2021cites this paper
• Cxcl10 deficiency attenuates renal interstitial fibrosis through regulating epithelial-to-mesenchymal transition.

  2021cites this paper
• The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis

  2021cites this paper
• Developmental histology of the portal plate in biliary atresia: observations and implications

  2021cites this paper
• The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma

  2021cites this paper
• The Tumor Microenvironment in Cholangiocarcinoma Progression

  2020cites this paper
• Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

  2020cites this paper
• Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?

  2020cites this paper
• Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells.

  2020cites this paper
• The Vascular Involvement in Soft Tissue Fibrosis—Lessons Learned from Pathological Scarring

  2020cites this paper
• Mechanisms of liver fibrosis and its role in liver cancer

  2020cites this paper
• A genetic system for tissue-specific inhibition of cell proliferation

  2020cites this paper
• Molecular and cellular mechanisms of liver fibrosis and its regression

  2020cites this paper
• SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial–mesenchymal transition

  2020cites this paper
• Origin and functional heterogeneity of fibroblasts

  2020cites this paper
• Immune-Mediated Liver Disease in the Transplanted Liver

  2020cites this paper
• Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo

  2019cites this paper
• A critical role of autophagy in regulating the mesenchymal transition of ductular cells in liver cirrhosis

  2019cites this paper
• Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC)

  2019cites this paper
• Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets

  2019cites this paper
• c‐Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor‐β‐Induced Epithelial–Mesenchymal Transition and Regulates Cell Phenotypic Switch

  2019cites this paper
• Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts

  2019cites this paper
• The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma

  2019cites this paper
• Signal Transduction in Disease

  2019cites this paper
• Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.

  2019cites this paper
• Melatonin Inhibits Transforming Growth Factor-β1-Induced Epithelial–Mesenchymal Transition in AML12 Hepatocytes

  2019cites this paper
• The tumour microenvironment and immune milieu of cholangiocarcinoma

  2019cites this paper
• Exosomes：carriers of pro-fibrotic signals and therapeutic targets in fibrosis.

  2019cites this paper
• TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer

  2018cites this paper
• Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis

  2018cites this paper
• Involvement of epithelial–mesenchymal transition in liver fibrosis

  2018cites this paper
• 5 – The Liver's Response to Injury: Inflammation and Fibrosis

  2018cites this paper
• Toll-like receptor 4 shRNA attenuates lipopolysaccharide-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells in rats.

  2018cites this paper
• Recent advances in understanding bile duct remodeling and fibrosis

  2018cites this paper
• The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands

  2018cites this paper
• The perivascular origin of pathological fibroblasts.

  2018cites this paper
• 2.16 – Mechanisms of Liver Fibrosis☆

  2018cites this paper
• Autocrine transforming growth factor-β/activin A-Smad signaling induces hepatic progenitor cells undergoing partial epithelial-mesenchymal transition states.

  2018cites this paper
• Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes.

  2018cites this paper
• TGF-β1 Signaling and Tissue Fibrosis.

  2018cites this paper
• Origins of fibroblasts in rheumatoid synovial tissues: Implications from organ fibrotic models

  2018cites this paper
• Drug targeting to myofibroblasts: Implications for fibrosis and cancer

  2017cites this paper
• Therapeutic pro-fibrogenic signaling pathways in fibroblasts.

  2017cites this paper
• Emerging concepts in biliary repair and fibrosis.

  2017cites this paper
• Can a fibrotic liver afford epithelial-mesenchymal transition?

  2017cites this paper
• Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways

  2017cites this paper
• Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma

  2017cites this paper
• New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets.

  2017cites this paper
• The origin of fibrogenic myofibroblasts in fibrotic liver

  2017cites this paper
• Hepatic Fibrosis in Dogs

  2017cites this paper
• Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.

  2017cites this paper
• Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.

  2017cites this paper
• Oval Cells Contribute to Fibrogenesis of Marginal Liver Grafts under Stepwise Regulation of Aldose Reductase and Notch Signaling

  2017cites this paper
• Potential involvement of epithelial-mesenchymal transition in the pathogenesis of periodontitis

  2017influential citation
• Carnosol‐mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis

  2017cites this paper
• Hepatic stellate cells as key target in liver fibrosis.

  2017cites this paper
• Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.

  2016cites this paper
• Cirrhosis and autoimmune liver disease: Current understanding

  2016cites this paper
• Myofibroblasts Derived from Hepatic Progenitor Cells Create the Tumor Microenvironment

  2016influential citation
• The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.

  2016cites this paper
• Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice

  2016cites this paper
• New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article

  2016cites this paper
• Translational studies in biliary atresia

  2016cites this paper
• Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the “Reactive” Biliary Epithelial Phenotype

  2016cites this paper
• The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration

  2016cites this paper
• Promising Therapy Candidates for Liver Fibrosis

  2016cites this paper
• Role of epithelial to mesenchymal transition in hepatocellular carcinoma.

  2016cites this paper
• Basement membrane fragments in the context of the epithelial-to-mesenchymal transition.

  2016cites this paper
• Epithelial-mesenchymal transition: An emerging target in tissue fibrosis

  2016cites this paper
• Immune Mechanisms in Pulmonary Fibrosis.

  2016cites this paper
• Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?

  2016cites this paper
• EMT: 2016.

  2016cites this paper
• Discoidin Domain Receptors in Liver Fibrosis

  2016cites this paper
• Implications physiopathologiques de la Nestine lors du remodelage pulmonaire et cardiaque à la suite de l’infarctus du myocarde, du diabète et de l’hypertension pulmonaire

  2016cites this paper
• Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis

  2016cites this paper
• The rationale for targeting TGF‐β in chronic liver diseases

  2016cites this paper
• Potent natural products and herbal medicines for treating liver fibrosis

  2015cites this paper
• Experimental models of liver fibrosis

  2015cites this paper
• Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis

  2015cites this paper